Acesion's positive trial data for treatment of atrial fibrillation
Positive data from a phase 2 clinical trial has proven the general mechanism of action of SK channel inhibition for treatment of atrial fibrillation (AF), an abnormal heart rhythm.
Archives for March 19, 2023